Fed. Circ. Says Drug Co. Briefs Too Long In Suboxone Appeal
Dr. Reddy's, Teva and Par Pharmaceutical will have to get together for a redo on their opening briefs in an appeal of a Delaware federal court's decision in a Suboxone-related patent...To view the full article, register now.
Already a subscriber? Click here to view full article